Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose TBI/G-CSF-combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients With Non-Remission Myeloid Malignancies
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.004
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV